Dipna Pharmachem (DPL) | Stock Overview & Key Data
Dipna Pharmachem Performance Comparison
Stock Range
Today's Range
Low: ₹23.11
High: ₹23.98
on July 30, 2025
52 Week Range
Low: ₹11.45
High: ₹542.55
on February 25, 2025
on September 24, 2024
All-Time High: ₹558.00 on January 29, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR565.0M
EPS
0.41
P/E Ratio (TTM)
55.73
Forward P/E
N/A
P/B Ratio
1.39
PEG Ratio
N/A
Div. Yield
23.16%
ROE
2.56%
Beta
-0.206
Debt to Equity
44.74
Financial Highlights
Profitability
Gross Margin
44.45%
Operating Margin
5.69%
Profit Margin
0.78%
Returns and Earnings
Return on Assets (TTM)
1.61%
Return on Equity (TTM)
2.56%
EBITDA
INR3.2B
Net Income (TTM)
INR9.7M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR51.95
Quarterly Revenue Growth (YoY)
-62.00%
Quarterly Earnings Growth (YoY)
28.80%
Dividend Information
Last 12-Month Dividend
₹5.00
Current Dividend Yield
23.16%
3-Year Average Dividend Yield
1.72%
3-Year Average Annual Dividend
₹6.00
3-Year Total Dividends
₹18.00
Ex-Dividend Date
August 13, 2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Dipna Pharmachem DPL | 564.97M Small-cap | -2.38% | 5.35% | 11.20% | 67.16% | 63.26% | -94.59% | -88.31% | -54.06% |
| Medplus Health MEDPLUS | 107.27B Mid-cap | 0.94% | 0.73% | 11.06% | 25.62% | 7.38% | 35.30% | 23.24% | -15.33% |
| Sastasundar Ventures SASTASUNDR | 9.71B Small-cap | -1.58% | -1.65% | 12.30% | 2.13% | -8.10% | -6.21% | 0.09% | 214.49% |
| Trident Lifeline TLL | 3.17B Small-cap | 3.45% | -4.98% | -10.22% | 1.38% | -3.98% | -6.93% | 114.56% | 114.56% |
| One Global Service ONEGLOBAL | 1.90B Small-cap | 6.33% | 13.28% | -13.41% | -1.61% | -18.09% | 82.39% | 640.19% | 6,266.03% |
| Murae Organisor MURAE | 1.80B Small-cap | -4.49% | -16.67% | 7.59% | -9.57% | -21.30% | 13.33% | -42.57% | -76.12% |
Ownership & Short Interest
Insider Ownership
45.45%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
44K
Average 90-Day Volume
83K
Dipna Pharmachem Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Dipna Pharmachem would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is DPL's 52-week high and low?
- In the last 52 weeks, Dipna Pharmachem reached a high of ₹542.55 (on September 24, 2024) and a low of ₹11.45 (on February 25, 2025).
- What is the market cap and P/E ratio for DPL?
- Curious about Dipna Pharmachem's size and valuation? Its market capitalization stands at 564.97M. When it comes to valuation, the P/E ratio (trailing twelve months) is 55.73, and the forward P/E (looking ahead) is N/A.
- Does DPL pay dividends? If so, what's the yield?
- Yes, Dipna Pharmachem is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 23.16%, and the company has paid an average of ₹6.00 per share annually over the past 3 years.
- Who are Dipna Pharmachem's main competitors or similar companies to consider before investing?
When looking at Dipna Pharmachem, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Medplus Health
MEDPLUS107.27B Healthcare Pharmaceutical Retailers 35.30% 23.24% Sastasundar Ventures
SASTASUNDR9.71B Healthcare Pharmaceutical Retailers -6.21% 0.09% Trident Lifeline
TLL3.17B Healthcare Pharmaceutical Retailers -6.93% 114.56% One Global Service
ONEGLOBAL1.90B Healthcare Pharmaceutical Retailers 82.39% 640.19% Murae Organisor
MURAE1.80B Healthcare Pharmaceutical Retailers 13.33% -42.57% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Dipna Pharmachem Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Dipna Pharmachem's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 2.56%, the Debt to Equity ratio from the most recent quarter is 44.74, and its Gross Profit Margin stands at 44.45%.
- What is the recent revenue and earnings growth for DPL?
- Looking at Dipna Pharmachem's growth, its revenue over the trailing twelve months (TTM) was INR1B. Compared to the same quarter last year (YoY), quarterly revenue grew by -62.00%, and quarterly earnings saw a YoY growth of 28.80%.
- How much of DPL stock is held by insiders and institutions?
- Wondering who owns Dipna Pharmachem stock? Company insiders (like executives and directors) hold about 45.45% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.